← All indications
Myositis Ossificans
A disease characterized by bony deposits or the ossification of muscle tissue.
Drugs by status
Approved for this indication (1)
Phase 3 trials (1)
Phase 2 trials (3)
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (14)
- AstraZeneca
- University of Pennsylvania
- University of London
- Harvard University
- Hospital Italiano de Buenos Aires
- Mayo Clinic
- University of California, San Francisco
- University of Amsterdam
- Free University of Amsterdam
- University of Oxford
- European Commission
- Queensland University of Technology
- Royal National Orthopaedic Hospital NHS Trust
- Klinikum Garmisch-Patenkirchen